ABOUT
The benefits of mindfulness, meditation and yoga on human health, wellness and creativity are well established. BioScience Innovations is a start-up stage venture that is developing non-invasive neuromodulation technologies and devices to enhance these benefits.
LEADERSHIP
David Francischelli is President and Founder of BioScience Innovations, LLC. He has spent his career developing devices to treat structural heart disease, arrhythmias, cancer and pain for companies ranging from start-up stage to Fortune-100. David is an accomplished innovator, holding 74 granted U.S. patents and was named a Top Inventor by Twin Cities Business. Additionally, he has authored over 30 peer-reviewed manuscripts and book chapters, and was recognized by Penn State University as an Outstanding Engineering Alumni.
The medical solutions that David has brought to market have impacted the lives of millions of patients worldwide. During David's most recent role as Vice President of Research, Development and Operations for Francis Medical, he led the development of the Vanquish System as an alternative treatment for prostate cancer with greater efficacy an lower morbidity than current standards of care. While with AtriCure, Inc, he successfully developed and launched over a dozen new medical devices, that have bettered the lives of patients suffering from cardiac diseases or debilitating pain.
David’s interest in neuromodulation started early in his career at Medtronic, Inc – the world’s largest medical device company. He led the R&D efforts to develop therapies and technologies that employed functional electrical stimulation (FES) to leverage the body’s own energy supply for treating heart failure.
David graduated from the Wharton Leadership Development Program, holds an MBA in Entrepreneurship from The University of Saint Thomas, an MS in Bioengineering from Pennsylvania State University and a BA in Biology from Saint Michael's College.